Cargando…
The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov
BACKGROUND: Well-designed clinical trials are of great importance in validating novel treatments and ensuring an evidence-based approach for sarcoma. This study aimed to provide a comprehensive landscape of the characteristics of metastatic or advanced sarcoma clinical trials using the substantial r...
Autores principales: | Que, Y, Xiao, W, Xu, BS, Wen, XZ, Weng, DS, Zhang, X |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293634/ https://www.ncbi.nlm.nih.gov/pubmed/30545340 http://dx.doi.org/10.1186/s12885-018-5163-2 |
Ejemplares similares
-
Registration of phase 3 crossover trials on ClinicalTrials.gov
por: Zeng, Lijuan, et al.
Publicado: (2020) -
Characteristics of Depression Clinical Trials Registered on ClinicalTrials.gov
por: Liang, Juan, et al.
Publicado: (2022) -
Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020
por: Gresham, Gillian, et al.
Publicado: (2022) -
Some data quality issues at ClinicalTrials.gov
por: Chaturvedi, Neha, et al.
Publicado: (2019) -
Obstacles to the reuse of study metadata in ClinicalTrials.gov
por: Miron, Laura, et al.
Publicado: (2020)